Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (36)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
C. BHARAT ; P. WEBB ; Z. WILKINSON ; R. McKETIN ; J. GREBELY ; M. FARRELL ; A. HOLLAND ; M. HICKMAN ; L. T. TRAN ; B. CLARK ; A. PEACOCK ; S. DARKE ; J. H. LI ; L. DEGENHARDT |BACKGROUND AND AIMS: Studies often rely upon self-report and biological testing methods for measuring illicit drug use, although evidence for their agreement is limited to specific populations and self-report instruments. We aimed to examine com[...]
Article : Périodique
M. ALAVI ; J. GREBELY ; M. MICALLEF ; A. J. DUNLOP ; A. C. BALCOMB ; C. A. DAY ; C. TRELOAR ; N. BATH ; P. S. HABER ; G. J. DORE |BACKGROUND: Access to hepatitis C virus (HCV) treatment remains extremely limited among people who inject drugs (PWID). HCV assessment and treatment was evaluated through an innovative model for the provision of HCV care among PWID with chronic [...]
Article : Périodique
L. A. HINES ; A. TRICKEY ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; L. DEGENHARDT ; S. COLLEDGE ; M. HICKMAN ; J. GREBELY ; E. B. CUNNINGHAM ; J. STONE ; K. DUMCHEV ; P. GRIFFITHS ; P. VICKERMAN ; R. P. MATTICK ; M. LYNSKEY |BACKGROUND: Globally, an estimated 15.6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the associ[...]
Article : Périodique
BACKGROUND: A systematic review was conducted to determine whether behavioural interventions are effective in preventing transmission of hepatitis C virus (HCV) amongst people who inject drugs. METHODS: Medline, EMBASE, the Cochrane Clinical T[...]![Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs [Commentary]](https://bdoc.ofdt.fr/thumbnail.php?type=1&id=76282)
Article : Périodique
S. LARNEY ; J. GREBELY ; M. HICKMAN ; D. DE ANGELIS ; G. J. DORE ; L. DEGENHARDT |There is considerable interest in determining the impact that increased uptake of treatment for hepatitis C virus (HCV) infection will have on the burden of HCV among people who inject drugs (PWID). An understanding of the size of the population[...]
Article : Périodique
E. ASPINALL ; A. WEIR ; R. SACKS-DAVIS ; T. SPELMAN ; J. GREBELY ; P. HIGGS ; S. J. HUTCHINSON ; M. E. HELLARD |BACKGROUND: People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce their injecting risk out of concern for their injecting partners, although evidence for this [...]
Article : Périodique
J. GREBELY ; G. J. DORE ; S. MORIN ; J. K. ROCKSTROH ; M. B. KLEIN |INTRODUCTION: Globally, there is a considerable burden of HCV and HIV infections among people who inject drugs (PWID) and transmission of both infections continues. Needle and syringe programme (NSP) and opioid substitution therapy (OST) coverag[...]
Article : Périodique
J. GREBELY ; B. HAJARIZADEH ; J. V. LAZARUS ; J. BRUNEAU ; C. TRELOAR ; International Network on Hepatitis in Substance Users |There have been major strides towards the World Health Organization goal to eliminate hepatitis C virus (HCV) infection as a global public health threat. The availability of simple, well-tolerated direct-acting antiviral therapies for HCV infect[...]
Bulletin : Périodique
International Journal of Drug Policy, Vol.47 - September 2017 - Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy
J. GREBELY ; J. BRUNEAU ; P. BRUGGMANN ; M. HARRIS ; M. HICKMAN ; T. RHODES ; C. TRELOAR, Éditeur scientifique | 2017
Article : Périodique
L. DEGENHARDT ; P. WEBB ; S. COLLEDGE-FRISBY ; J. IRELAND ; A. WHEELER ; S. OTTAVIANO ; A. WILLING ; A. KAIROUZ ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; L. T. TRAN ; O. PRICE ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; J. GREBELY |BACKGROUND: People who inject drugs are exposed to various and changing risk environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed to undertake a global systematic review of the prevalence of IDU, key IDU-r[...]
Article : Périodique
S. LARNEY ; M. HICKMAN ; R. GUY ; J. GREBELY ; G. J. DORE ; R. T. GRAY ; C. A. DAY ; J. KIMBER ; L. DEGENHARDT |Background: Injecting drug use is associated with considerable morbidity and mortality. Estimates of the size of the population of people who inject drugs are critical to inform service planning and estimate disease burden due to injecting drug [...]
Bulletin : Périodique
International Journal of Drug Policy, Vol.26, n°10 - October 2015 - Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
J. GREBELY, Éditeur scientifique ; P. BRUGGMANN, Éditeur scientifique ; C. TRELOAR, Éditeur scientifique ; G. J. DORE, Éditeur scientifique | 2015![Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs [Editorial]](https://bdoc.ofdt.fr/thumbnail.php?type=1&id=76280)
Article : Périodique
Article : Périodique
S. COLLEDGE ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; J. GREBELY ; M. HICKMAN ; E. CUNNINGHAM ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; L. DEGENHARDT |BACKGROUND: People who inject drugs (PWID) do so at varying frequencies. More frequent injecting is associated with skin and soft tissue infection, blood borne viruses, and overdose. The aims of this review are to estimate the prevalence of inje[...]
Article : Périodique
S. COLLEDGE-FRISBY ; S. OTTAVIANO ; P. WEBB ; J. GREBELY ; A. WHEELER ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; L. DEGENHARDT |BACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid [...]
